Where is AbbVie Inc. (ABBV) Headed According to the Street?

AbbVie Inc. (NYSE:ABBV) is one of the best medical research stocks to buy according to hedge funds. AbbVie Inc. (NYSE:ABBV) received rating updates from Guggenheim and UBS on February 5, with Guggenheim reaffirming a Buy rating on the stock with a $242 price target and UBS revising the price target to $230 from $240 while keeping a Neutral rating on the shares. Citi Sees a More Supportive Backdrop Forming for AbbVie (ABBV) and Biopharma Evercore ISI also adjusted the price target on AbbVie Inc. (NYSE:ABB ...